News
Medtronic (NYSE: MDT) today announced a new interim analysis evaluating automated sacral neuromodulation (SNM) therapy.
Dublin, April 30, 2025 (GLOBE NEWSWIRE) -- The "Sacral Nerve Stimulation (SNS) Market 2025-2035: A Global and Regional Analysis - Focus on Product, Application, End User and Country" report has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback